Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt: 2023-2025

Historic Non-Current Debt for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Jun 2025 value amounting to $649,788.

  • Zhengye Biotechnology Holding's Non-Current Debt was N/A to $649,788 in Q2 2025 from the same period last year, while for Jun 2025 it was $649,788, marking a year-over-year change of. This contributed to the annual value of $658,000 for FY2024, which is 53.45% down from last year.
  • Zhengye Biotechnology Holding's Non-Current Debt amounted to $2,000.0 billion in Q2 2025.
  • In the past 5 years, Zhengye Biotechnology Holding's Non-Current Debt registered a high of $1.4 million during Q4 2023, and its lowest value of $649,788 during Q2 2025.
  • Over the past 3 years, Zhengye Biotechnology Holding's median Non-Current Debt value was $658,000 (recorded in 2024), while the average stood at $898,424.
  • Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Non-Current Debt was -52.58% (2024), while the steepest drop was 52.58% (2024).
  • Zhengye Biotechnology Holding's Non-Current Debt (MRQ) stood at $1.4 million in 2023, then tumbled by 52.58% to $658,000 in 2024, then fell by 1.25% to $649,788 in 2025.
  • Its Non-Current Debt was $649,788 in Q2 2025, compared to $658,000 in Q4 2024 and $1.4 million in Q4 2023.